Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34794066)

  • 1. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
    Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
    Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.
    Watts K; Wills C; Madi A; Palles C; Maughan TS; Kaplan R; Al-Tassan NA; Kerr R; Kerr D; Gray V; West H; Houlston RS; Escott-Price V; Cheadle JP
    Int J Cancer; 2021 Nov; 149(9):1713-1722. PubMed ID: 34270794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
    Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
    Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
    Quintanilha JCF; Wang J; Sibley AB; Xu W; Espin-Garcia O; Jiang C; Etheridge AS; Ratain MJ; Lenz HJ; Bertagnolli M; Kindler HL; Dickler MN; Venook A; Liu G; Owzar K; Lin D; Innocenti F
    Int J Cancer; 2022 Jan; 150(2):279-289. PubMed ID: 34528705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
    Gray V; Briggs S; Palles C; Jaeger E; Iveson T; Kerr R; Saunders MP; Paul J; Harkin A; McQueen J; Summers MG; Johnstone E; Wang H; Gatcombe L; Maughan TS; Kaplan R; Escott-Price V; Al-Tassan NA; Meyer BF; Wakil SM; Houlston RS; Cheadle JP; Tomlinson I; Church DN
    J Natl Cancer Inst; 2019 Aug; 111(8):828-836. PubMed ID: 30649440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
    Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
    Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
    Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
    Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer.
    Qu X; Zhao L; Wang M; Zhang R; Cheng L; Qiu L; Tong X; Cai S; Wei Q; Li Q
    Int J Cancer; 2021 Jul; 149(1):84-96. PubMed ID: 33728681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer.
    Kupcinskas J; Gyvyte U; Bruzaite I; Leja M; Kupcinskaite-Noreikiene R; Pauzas H; Tamelis A; Jonaitis L; Skieceviciene J; Kiudelis G
    Asian Pac J Cancer Prev; 2015; 16(14):6027-32. PubMed ID: 26320491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer susceptibility loci and influence on survival.
    Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
    Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the Angiogenesis-Related Genes
    Scherer D; Deutelmoser H; Balavarca Y; Toth R; Habermann N; Buck K; Kap EJ; Botma A; Seibold P; Jansen L; Lorenzo Bermejo J; Weigl K; Benner A; Hoffmeister M; Ulrich A; Brenner H; Burwinkel B; Chang-Claude J; Ulrich CM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series.
    Galvan A; Colombo F; Frullanti E; Dassano A; Noci S; Wang Y; Eisen T; Matakidou A; Tomasello L; Vezzalini M; Sorio C; Dugo M; Ambrogi F; Iacobucci I; Martinelli G; Incarbone M; Alloisio M; Nosotti M; Tosi D; Santambrogio L; Pelosi G; Pastorino U; Houlston RS; Dragani TA
    Int J Cancer; 2015 Mar; 136(5):E262-71. PubMed ID: 25196286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.
    Lin M; Eng C; Hawk ET; Huang M; Lin J; Gu J; Ellis LM; Wu X
    Cancer; 2012 Dec; 118(24):6188-98. PubMed ID: 22673945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).
    Innocenti F; Sibley AB; Patil SA; Etheridge AS; Jiang C; Ou FS; Howell SD; Plummer SJ; Casey G; Bertagnolli MM; McLeod HL; Auman JT; Blanke CD; Furukawa Y; Venook AP; Kubo M; Lenz HJ; Parker JS; Ratain MJ; Owzar K
    Clin Cancer Res; 2021 Jan; 27(1):267-275. PubMed ID: 32958699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
    Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
    Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.
    Phipps AI; Passarelli MN; Chan AT; Harrison TA; Jeon J; Hutter CM; Berndt SI; Brenner H; Caan BJ; Campbell PT; Chang-Claude J; Chanock SJ; Cheadle JP; Curtis KR; Duggan D; Fisher D; Fuchs CS; Gala M; Giovannucci EL; Hayes RB; Hoffmeister M; Hsu L; Jacobs EJ; Jansen L; Kaplan R; Kap EJ; Maughan TS; Potter JD; Schoen RE; Seminara D; Slattery ML; West H; White E; Peters U; Newcomb PA
    Carcinogenesis; 2016 Jan; 37(1):87-95. PubMed ID: 26586795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
    Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.